3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)

NCT00159796 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

489

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Asenapine
DRUG: Olanzapine
DRUG: Placebo

Sponsor

Organon and Co

Collaborators

[object Object]